Pfizer Inc (PFE)

$27.72 0.00 (N/A)
Market Cap 157.99B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 9.09
Forward PE 9.31
Profit Margin 12.42%
Debt to Equity Ratio 0.74
Volume 28,571,580
Avg Vol 37,452,707
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 18%
Beta 0.34
Analysts Sell
Price Target $28.92

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
jrh34
jrh34 Sep. 15 at 3:56 AM
$CRDF mPFS is up next, followed by an offer from $PFE for $1.2 Billion, which Cardiff will accept - it's a done deal. Pace isn't going to let them go it alone and chase a P3, that's never successful. Sell it at a discount is what will happen. Glad to see today's settlement. I will be adding more shares tomorrow.
2 · Reply
simonds
simonds Sep. 15 at 3:18 AM
$PFE they suck
0 · Reply
SuperGreenToday
SuperGreenToday Sep. 15 at 3:01 AM
$PFE Share Price: $27.74 Contract Selected: Oct 09, 2026 $30 Calls Buy Zone: $0.03 – $0.03 Target Zone: $0.05 – $0.06 Potential Upside: 79% ROI Time to Expiration: 24 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
jrh34
jrh34 Sep. 15 at 2:10 AM
$CRDF Is an $SLS type move or acquisition by $PFE to much to ask?
1 · Reply
smartfellar
smartfellar Sep. 14 at 9:59 PM
$PFE they will keep this below $28 all week so that my 1000s of calls expire worthless, sorry team
0 · Reply
JackedNicholson
JackedNicholson Sep. 14 at 9:30 PM
$ALT $NVO $NVS $SNY $PFE
2 · Reply
edlu77
edlu77 Sep. 14 at 7:46 PM
$PFE Well today was embarrassing
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 14 at 6:21 PM
$SLS $JNJ$AZN $PFE Only☝️ Thing that requires this kind of 🤐 at this point is an outright BO! ✌️🙏❤️‍🩹
1 · Reply
taxplanr
taxplanr Sep. 14 at 5:35 PM
The zionist's were covering up COVID vaccines deaths also $MRNA $PFE $BNTX https://www.instagram.com/reel/DdReFG2xP_B/?stkn=ZmRlMnU4bGRwb2gz
4 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Sep. 14 at 2:56 PM
$PFE
0 · Reply
Latest News on PFE
Pfizer Transcript: Morgan Stanley 24th Annual Global Healthcare Conference

Sep 14, 2026, 10:45 AM EDT - 15 hours ago

Pfizer Transcript: Morgan Stanley 24th Annual Global Healthcare Conference

Pfizer aims at air-traffic controllers for Covid-19 vaccine money, WSJ says

2026-09-14T00:45:06.000Z - 1 day ago

Pfizer aims at air-traffic controllers for Covid-19 vaccine money, WSJ says

Pfizer Makes an Unusual Enemy in $2 Billion Fight Over Unwanted Covid-19 Vaccines

Sep 13, 2026, 10:39 AM EDT - 1 day ago

Pfizer Makes an Unusual Enemy in $2 Billion Fight Over Unwanted Covid-19 Vaccines

Here are the stocks to favor in the fourth quarter — and those you should avoid

Sep 10, 2026, 6:02 PM EDT - 4 days ago

Here are the stocks to favor in the fourth quarter — and those you should avoid

AAPL ABT ADBE AMZN AVGO BAC BMY

Pfizer price target raised to $30 from $28 at HSBC

2026-09-10T10:25:13.000Z - 4 days ago

Pfizer price target raised to $30 from $28 at HSBC

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Sep 8, 2026, 10:00 AM EDT - 6 days ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Vaxcyte names Luis Jodar chief medical officer, David McAvoy chief legal officer

2026-09-03T20:30:28.000Z - 11 days ago

Vaxcyte names Luis Jodar chief medical officer, David McAvoy chief legal officer

PCVX TEVA

Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities

Sep 2, 2026, 9:00 AM EDT - 12 days ago

Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities

XRAY

Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers

Aug 31, 2026, 1:20 PM EDT - 14 days ago

Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers

LLY NVO TAK

Trump administration to announce drug pricing deals

Aug 31, 2026, 12:09 PM EDT - 14 days ago

Trump administration to announce drug pricing deals

AMGN LLY TAK

US FDA approves updated COVID vaccines for 2026-27 season

Aug 27, 2026, 5:48 PM EDT - 18 days ago

US FDA approves updated COVID vaccines for 2026-27 season

MRNA NVAX SNY BNTX

Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine

2026-08-27T20:35:15.000Z - 18 days ago

Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine

BNTX

Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

Aug 27, 2026, 4:30 PM EDT - 18 days ago

Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

BNTX

White House to announce new drug pricing deals with biotechs, Bloomberg News reports

Aug 26, 2026, 12:48 PM EDT - 19 days ago

White House to announce new drug pricing deals with biotechs, Bloomberg News reports

AMGN LLY

Pfizer Stock (PFE) Is a Buy despite Declining Revenue

2026-08-24T12:18:00.000Z - 21 days ago

Pfizer Stock (PFE) Is a Buy despite Declining Revenue

Pfizer (PFE) Stock Rallies 4% Thanks to Merck (MRK) and Moderna (MRNA)’s Cancer Trial Update

2026-08-19T14:35:12.000Z - 26 days ago

Pfizer (PFE) Stock Rallies 4% Thanks to Merck (MRK) and Moderna (MRNA)’s Cancer Trial Update

BNTX MRK MRNA

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

2026-08-16T13:55:21.000Z - 4 weeks ago

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

VALN

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Aug 14, 2026, 1:45 PM EDT - 4 weeks ago

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Closed Pfizer biopharma facility in Everett gets a new lease on life

Aug 14, 2026, 11:46 AM EDT - 4 weeks ago

Closed Pfizer biopharma facility in Everett gets a new lease on life

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

Aug 14, 2026, 11:11 AM EDT - 4 weeks ago

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Aug 14, 2026, 1:00 AM EDT - 4 weeks ago

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

VALN

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 5 weeks ago

Pfizer Earnings Call Transcript: Q2 2026

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 5 weeks ago

Pfizer Earnings release: Q2 2026

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 5 weeks ago

Pfizer Slides: Q2 2026

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 5 weeks ago

Pfizer Quarterly report: Q2 2026

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 5 weeks ago

Pfizer Post Loss on Higher Revenue

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:13 AM EDT - 5 weeks ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

Aug 4, 2026, 7:12 AM EDT - 5 weeks ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:52 AM EDT - 5 weeks ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Aug 4, 2026, 6:45 AM EDT - 5 weeks ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 7:48 AM EDT - 6 weeks ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 30, 2026, 6:45 AM EDT - 6 weeks ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

Jul 29, 2026, 4:30 PM EDT - 6 weeks ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:48 PM EDT - 7 weeks ago

Pfizer's prostate cancer drug combination gets US FDA priority review

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 22, 2026, 4:30 PM EDT - 7 weeks ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

Jul 21, 2026, 7:10 PM EDT - 7 weeks ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 16, 2026, 1:39 PM EDT - 2 months ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 10, 2026, 11:23 AM EDT - 2 months ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 2 months ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

Jun 29, 2026, 4:43 PM EDT - 2 months ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 29, 2026, 1:20 AM EDT - 2 months ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 2 months ago

Pfizer Declares Third-Quarter 2026 Dividend

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 2:10 PM EDT - 2 months ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 2 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 12:10 PM EDT - 2 months ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 23, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 4:30 PM EDT - 2 months ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

Jun 22, 2026, 2:32 PM EDT - 2 months ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August

Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 10, 2026, 7:56 AM EDT - 3 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

Jun 9, 2026, 2:07 PM EDT - 3 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Jun 9, 2026, 9:20 AM EDT - 3 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

Jun 9, 2026, 3:20 AM EDT - 3 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 8:00 AM EDT - 3 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 3 months ago

US FDA approves Pfizer's bleeding disorder drug for children

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 8, 2026, 6:45 AM EDT - 3 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Transcript: Study update

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Slides: Study update

Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Press release: Study update

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:06 AM EDT - 3 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 6, 2026, 9:00 AM EDT - 3 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 10:00 AM EDT - 3 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

Jun 4, 2026, 6:40 AM EDT - 3 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 3 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 31, 2026, 8:00 AM EDT - 3 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

jrh34
jrh34 Sep. 15 at 3:56 AM
$CRDF mPFS is up next, followed by an offer from $PFE for $1.2 Billion, which Cardiff will accept - it's a done deal. Pace isn't going to let them go it alone and chase a P3, that's never successful. Sell it at a discount is what will happen. Glad to see today's settlement. I will be adding more shares tomorrow.
2 · Reply
simonds
simonds Sep. 15 at 3:18 AM
$PFE they suck
0 · Reply
SuperGreenToday
SuperGreenToday Sep. 15 at 3:01 AM
$PFE Share Price: $27.74 Contract Selected: Oct 09, 2026 $30 Calls Buy Zone: $0.03 – $0.03 Target Zone: $0.05 – $0.06 Potential Upside: 79% ROI Time to Expiration: 24 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
jrh34
jrh34 Sep. 15 at 2:10 AM
$CRDF Is an $SLS type move or acquisition by $PFE to much to ask?
1 · Reply
smartfellar
smartfellar Sep. 14 at 9:59 PM
$PFE they will keep this below $28 all week so that my 1000s of calls expire worthless, sorry team
0 · Reply
JackedNicholson
JackedNicholson Sep. 14 at 9:30 PM
$ALT $NVO $NVS $SNY $PFE
2 · Reply
edlu77
edlu77 Sep. 14 at 7:46 PM
$PFE Well today was embarrassing
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 14 at 6:21 PM
$SLS $JNJ$AZN $PFE Only☝️ Thing that requires this kind of 🤐 at this point is an outright BO! ✌️🙏❤️‍🩹
1 · Reply
taxplanr
taxplanr Sep. 14 at 5:35 PM
The zionist's were covering up COVID vaccines deaths also $MRNA $PFE $BNTX https://www.instagram.com/reel/DdReFG2xP_B/?stkn=ZmRlMnU4bGRwb2gz
4 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Sep. 14 at 2:56 PM
$PFE
0 · Reply
Joker_brz
Joker_brz Sep. 14 at 1:47 PM
$PFE reminds me of old days .. when market red , this would rippp ..
0 · Reply
Letsgofam
Letsgofam Sep. 14 at 1:41 PM
$PFE cry babies in here lol
0 · Reply
HydrogenH2
HydrogenH2 Sep. 14 at 1:06 PM
$PFE Dividend Payout is @ 126.85% according to Finviz ?? What's next ??
0 · Reply
Sdwg
Sdwg Sep. 14 at 1:03 PM
$PFE lol some green in a sea of red!
0 · Reply
markbrogan
markbrogan Sep. 14 at 12:59 PM
$PFE why not?
0 · Reply
Outcomes
Outcomes Sep. 14 at 12:14 PM
$IBRX $MRNA $MRK $PFE $JNJ .....'Turbo-cancers' PSS KNOWS. https://x.com/docBenk12/status/2099104918783098994?s=20
2 · Reply
Outcomes
Outcomes Sep. 14 at 11:12 AM
$IBRX $NRXP $PFE $MRNA $MRK RFK Jr. knows. JayB knows. DJT knows. https://x.com/RobertKennedyJr/status/2099203137974222886?s=20
0 · Reply
Outcomes
Outcomes Sep. 14 at 10:59 AM
$IBRX $NRXP $PFE $MRNA $MRK .....Beware Big Pharma, Beware Bureaucrats mRNA BAD. SAVE THE CHILDREN 🙏 PSS knows. https://x.com/i/trending/2099295875323277431?s=20
2 · Reply
jrh34
jrh34 Sep. 14 at 10:01 AM
$PFE AI rotation into safety, should be a very Green Day in this ticker.
1 · Reply
zustrelaax
zustrelaax Sep. 14 at 1:38 AM
$PFE given the tech weakness this week goo time to drop the pr for a good 20% move
2 · Reply
Xen_TorpedoCapital
Xen_TorpedoCapital Sep. 13 at 3:50 PM
$AMD $MRVL $INTC $PFE $ARM Please check the new ranking for Monday's session in comment of the original post below God bless America 🇺🇸
0 · Reply
NorthOfSouth
NorthOfSouth Sep. 13 at 2:07 PM
$PFE 28 and possibly 29 this coming week...AI freakout over anthropic delay and questions about ai regulation ...
0 · Reply